1. Home
  2. DGX vs LII Comparison

DGX vs LII Comparison

Compare DGX & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$182.89

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Logo Lennox International Inc.

LII

Lennox International Inc.

HOLD

Current Price

$511.08

Market Cap

17.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGX
LII
Founded
1967
1895
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
20.5B
17.4B
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
DGX
LII
Price
$182.89
$511.08
Analyst Decision
Buy
Hold
Analyst Count
15
12
Target Price
$194.07
$605.18
AVG Volume (30 Days)
1.2M
451.7K
Earning Date
10-21-2025
10-22-2025
Dividend Yield
1.75%
1.02%
EPS Growth
14.49
12.46
EPS
8.51
23.67
Revenue
$10,850,000,000.00
$5,345,300,000.00
Revenue This Year
$12.37
N/A
Revenue Next Year
$3.52
$7.34
P/E Ratio
$21.44
$21.62
Revenue Growth
13.74
3.77
52 Week Low
$148.70
$443.19
52 Week High
$197.55
$689.44

Technical Indicators

Market Signals
Indicator
DGX
LII
Relative Strength Index (RSI) 44.87 60.54
Support Level $184.18 $481.60
Resistance Level $185.12 $499.95
Average True Range (ATR) 3.22 14.23
MACD -0.78 6.58
Stochastic Oscillator 3.85 99.78

Price Performance

Historical Comparison
DGX
LII

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

About LII Lennox International Inc.

Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.

Share on Social Networks: